CPNI representatives met with the Permanent Secretary (Department of Health NI) and health service officials yesterday afternoon in Belfast.
The Permanent Secretary confirmed that the Chief Pharmaceutical Officer, Mrs Cathy Harrison will undertake a rapid review of community pharmacy services, as outlined in the DoH(NI) statement released on Friday 18 November 2022.
CPNI conveyed again the grave nature of the current community pharmacy funding crisis and the need for urgent intervention to avert further service difficulties.
A further meeting with the Permanent Secretary and health service officials will take place w/c 5 December 2022.
Please do not hesitate to contact CPNI offices or your local CPNI Board Director representative should you require any additional information.
Yours sincerely
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Please see attached correspondence from the Department of Health.
SUMMARY
A number of individuals remain eligible for LFD tests and should be able to access these freely without the need to purchase privately. This is particularly important for those in advance of inpatient admission or treatment.
Pharmacies may experience an increase in demand due to the recommencement of the PANORAMIC antiviral study. Recruitment for the study closed on 27 April 2022.
From 23 November 2022, eligible members of the public in Northern Ireland can register for the study. More information on the study, including study eligibility and how people can sign up, is available at the PANORAMIC trial website.
PANORAMIC is open to anyone that meets the following criteria:
You are currently experiencing COVID-19 symptoms, beginning in the last 5 days;
AND You have had a positive PCR or Lateral Flow test for COVID-19;
Further information for the public is also available on NI Direct Treatments for coronavirus (COVID-19) webpage which details the above eligibility information and states if a person is in an eligible group. If they wish to take part in the study they can collect lateral flow tests from participating pharmacies.
People are advised they should not collect tests from a pharmacy if they have symptoms but should ask someone who does not have symptoms to collect the lateral flow tests on their behalf.
ACTION
Contractors are asked to review the attached correspondence and ensure pharmacy teams are aware of the communication.
Please ensure you retain sufficient stock to meet any increases in demand.
If you have any further queries, please contact the CPNI office.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
CPNI has produced the following resources to help pharmacy teams explain to their patients the reasons why some of their medicines may be out of stock, unavailable or delayed. We have also included a guide on how to use Twitter.
To ensure we can continue to monitor the situation we ask you to please continue to report using CPNI’s online reporting form:
any medicine shortages or
a medicine unavailable to purchase from your supplier(s) at or below the Drug Tariff listed price
We can continue to build an evidence base of issues affecting community pharmacies and patients, enabling us to liaise accordingly with the Department of Health NI (DHNI).
ACTION
Contractors are advised to bring these resources to the attention of pharmacy teams and those involved in the ordering and purchasing of medicines for your pharmacy(-ies).
If you have any further queries, please contact the CPNI office.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The second update of concessionary prices were granted yesterday for November 2022:
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF GERARD GREENE
Chief Executive
Dear Contractor
As discussed at last week’s contractor meeting, the frequency of abusive behaviour directed at community pharmacy teams specifically relating to medicine shortages has increased and to capture this rise in abuse, contractors are encouraged to complete this short survey HERE.
Please complete by 12 noon on today, Monday, 21 November 2022.
CPNI would ask community pharmacy teams in addition to notifying CPNI, to liaise with local PSNI teams and with their crime prevention officers, and to report all instances of abuse, aggression, or attacks to the Department of Health.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.
Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.